A double blinded placebo controlled comparative clinical trial to evaluate the effectiveness of Siddha medicines, Kaba Sura Kudineer (KSK) & Nilavembu Kudineer (NVK) along with standard Allopathy treatment in the management of symptomatic COVID 19 patients - a structured summary of a study protocol for a randomized controlled trial

Peer Review reports

Original Submission
8 Jan 2021	Submitted	Original manuscript
11 Jan 2021	Reviewed	Reviewer Report - Kirsty Loudon
Resubmission - Version 2
	Submitted	Manuscript version 2
Publishing
11 Jan 2021	Editorially accepted
11 Feb 2021	Article published	10.1186/s13063-021-05041-x

Back to article page